TipRanks
DBV Technologies SA - American (DBVT)
NASDAQ:DBVT
US Market
DBVT
DBV Technologies SA - American
RESEARCH TOOLSreports
Want to see DBVT full AI Analyst Report?

DBV Technologies SA - American (DBVT) Stock News & Sentiment

460 Followers
DBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
Premium
Ratings
DBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
11h ago
DBVT
DBV Technologies: Buy Rating Reaffirmed with Unchanged $46 Price Target as VIASKIN Peanut BLA Timeline and Regulatory Path De‑Risk
Premium
Ratings
DBV Technologies: Buy Rating Reaffirmed with Unchanged $46 Price Target as VIASKIN Peanut BLA Timeline and Regulatory Path De‑Risk
3M ago
DBVT
Fein Reiterates Buy on DBV Technologies, Citing Operational BLA Delay and Unchanged $40 Price Target
Premium
Ratings
Fein Reiterates Buy on DBV Technologies, Citing Operational BLA Delay and Unchanged $40 Price Target
3M ago
DBVT
DBV Advances VIASKIN Peanut Patch Toward FDA Submission
Premium
Company Announcements
DBV Advances VIASKIN Peanut Patch Toward FDA Submission
3M ago
8K
DBVT
DBV Technologies Shareholders Approve Governance and Capital Measures
Premium
Company Announcements
DBV Technologies Shareholders Approve Governance and Capital Measures
4M ago
8K
DBVT
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
Premium
Ratings
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
5M ago
DBVT
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
Premium
Ratings
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
5M ago
DBVT
More DBVT News >

DBVT News on the Web

DBV Seeks FDA Approval For VIASKIN Peanut Patch In Young Children
rttnews
Bullish
DBV Submits BLA For VIASKIN Peanut Patch In Children With Peanut Allergy
rttnews
Bullish
Fourteen new option listings and one option delisting on July 22nd
TipRanks News
Neutral
DBV Technologies announces $150M at-the-market offering
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Kalaris Therapeutics (KLRS)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), AbCellera Biologics (ABCL) and DBV Technologies SA – American (DBVT)
TipRanks News
Bullish
Cantor Fitzgerald Keeps Their Buy Rating on DBV Technologies SA – American (DBVT)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT), Intuitive Surgical (ISRG) and Staar Surgical (STAA)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DBVT
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DBVT’s Media Buzz Sentiment?
1 articles about DBVT were published this week. In an average week, 0.25 articles are published.
    What is DBVT’s weekly average amount of articles?
    In an average week, 0.25 articles about DBVT are published.
      What is DBVT’s News Sentiment?
      100% of articles about DBVT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        LGNDLigand Pharma
        MIRMMirum Pharmaceuticals
        AXSMAxsome Therapeutics
        ABBVAbbVie
        Showing the stocks with the most bullish news sentiment over the past week